• Channels
    • All News
    • Premium Content
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Af­ter rais­ing $140M, SPAC will take biotech pub­lic with a frac­tion of planned funds

2 days ago
Financing

Kite's head of re­search leaves for Flag­ship start­up Sonata

3 days ago
People
Startups

Con­tra­cep­tive mak­er Evofem lets com­mer­cial chief go, cuts CEO pay 40% to save cash

3 days ago
People

Karuna to raise $400M in mar­ket a day af­ter pos­i­tive read­out of schiz­o­phre­nia drug

3 days ago
Financing

So­bi's PhI­II gout win sets up a po­ten­tial ri­val­ry with fu­ture Am­gen as­set

3 days ago
R&D

Ab­b­Vie cel­e­brates decade of phar­ma work in newest cor­po­rate cam­paign

3 days ago
Pharma
Marketing

Most dos­es of No­vo Nordisk's Ozem­pic are re­moved from FDA drug short­age list af­ter sup­ply is­sues

3 days ago
Pharma
Manufacturing

FDA in­di­cates will­ing­ness to ap­prove Bio­gen ALS drug de­spite failed PhI­II study

3 days ago
R&D
FDA+

Sy­neos Health inks deal with Mi­crosoft to use AI tech­nol­o­gy

3 days ago
Deals
AI

'No find­ing of re­search mis­con­duc­t': MIT ends 3.5-year re­view of biotech founder, pro­fes­sor Sasisekha­ran

3 days ago
People

No­var­tis and Bio­gen pull out of neu­ro drug part­ner­ships with Sang­amo

4 days ago
Deals
Cell/Gene Tx

Karuna’s schiz­o­phre­nia drug clears an­oth­er PhI­II as biotech seeks 2024 launch

4 days ago
R&D

Seagen goes to Pfiz­er for $43B; Sanofi buys di­a­betes part­ner Proven­tion; Cri­sis avert­ed in SVB demise; and more

6 days ago
Weekly

Ve­rastem's new cam­paign aims to make dis­tinc­tions in rare type of ovar­i­an can­cer

6 days ago
Pharma
Marketing

Pfiz­er's Bourla and Mod­er­na's Ban­cel saw com­pen­sa­tion bumps in 2022

6 days ago
People
Pharma

BeiGene de­cides not to li­cense DKK1 drug, but keeps PD-1 com­bo tri­al in gas­tric can­cer

6 days ago
Deals

Mod­er­na's 'sur­prise' IP court or­der could set up a big set­tle­ment for Roivant, Ar­bu­tus — an­a­lysts

Last week
Law

Ul­tragenyx adds new CMO with in­ter­nal pro­mo­tion; Au­to­lus CFO to leave for Mor­phoSys — but not quite yet

Last week
Peer Review

Am­gen cites in­fla­tion, pres­sure on drug prices in 450-per­son lay­off

Last week
People
Pharma

Mer­ck­'s Keytru­da plus TIG­IT com­bo proves less ef­fec­tive than chemo in open-la­bel lung can­cer study

Last week
R&D
Pharma

Vi­iV's newest cam­paign aims to nor­mal­ize sex and health dis­cus­sions to help HIV pre­ven­tion among Black women

Last week
Pharma
Marketing

No­vo Nordisk sus­pend­ed from lead­ing UK trade group over obe­si­ty mar­ket­ing 'breach'

Last week
Pharma
Marketing

Seagen qui­et­ly doles out cell ther­a­py patent rights, but scope re­mains un­clear

Last week
Deals
Cell/Gene Tx

'Very re­al' head­winds: With lean­er staff, can­cer vac­cine mak­er search­es for help

Last week
Financing
R&D
First page Previous page 12345 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Premium Content
  • Don't Miss
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints Company 2023

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
Endpoints News

Log in to your account

e-mail

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

About You

Subscriptions

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

ENDPOINTS MARKETING RX Tue at 2 PM ET

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET